News about Biotechnology, Pharmaceutical and Healthcare

10:55 EDT 23rd May 2015 | BioPortfolio

Latest news articles in the life-science, healthcare, medical device, biotechnology and pharmaceuticals sectors. 

Showing News Articles 1–25 of 8,600+

Friday 22nd May 2015

Mars unwraps new product innovations

Ryan ChavisMars Chocolate North America this week unveiled a number of new products, along with some new consumer promotions and merchandising displays at the National Confectioners Association Sweets and Snacks Expo in Chicago. read more

Coty launches new Love2Love Bluebell + White Tea fragrance

Antoinette AlexanderHitting mass and drug retailers is the Love2Love Bluebell + White Tea fragrance, Coty has announced. read more

Forsake fashion for function, foot researchers say

Michael JohnsenInjuries from fashionable high heels are on the rise, but sales of footcare devices are relatively flat.  read more

New Softlips Cube Hello Kitty collection to hit retail

Antoinette AlexanderSanrio, parent company of Hello Kitty, and The Mentholatum Co.'s Softlips Cube 5-in-1 Lip Care will partner to launch a new lip balm collection beginning in July. read more

Kroger partners with USO in 'Honoring our Heroes'

Kroger has raised almost $12 million in the past five years to support the USO.  read more

U.K.'s CMA still weighing in on RB acquisition of K-Y

Michael JohnsenThe U.K.'s CMA feels that Reckitt-Benckiser acquisition of K-Y personal lubricants may lead to higher prices across the category.  read more

RPS reports deficit following period of investment

The Royal Pharmaceutical Society says financial position remains ‘very strong’.

Lumacaftor-ivacaftor combination improves lung function in cystic fibrosis

Combination therapy with two drugs that target the most common genetic cause of cystic fibrosis (CF) has been found to improve lung function in patients with the disease.

Healthcare Leadership Council's highlights APhA Foundation's diabetes management solution

Antoinette AlexanderThe American Pharmacists Association Foundation’s diabetes management solution, the Patient Self-Management Credential for Diabetes, was highlighted May 18 at the Healthcare Leadership Council’s wellness briefing entitled, Controlling Diabetes: Innovations in Therapies and Care.

The Phoenix House New England to honor CVS Health's Helena Foulkes

Antoinette AlexanderThe Phoenix House New England, a nonprofit treatment provider, will host on June 2 the 14th annual New England Public Service Award Luncheon at the Omni Providence Hotel, honoring Helena Foulkes, EVP, CVS Health, and president, CVS/pharmacy, for her leadership and contributions to the community. read more

Mammoth undertaking: CRISPR/Cas9 gene editing goes beyond medicine

Big Pharma is not the only slow moving behemoth involved in the CRISPR/Cas9 revolution with a US team citing the gene editing tech as key to its efforts to resurrect the woolly mammoth.

Thermo Fisher's $15bn war chest set to further consolidate industry

Danaher's acquisition of Pall will not change the competitive landscape in the bioprocessing tech industry says Thermo Fisher, as it earmarks $10bn for further M&A activity.

Health Care’s Climate Leadership: Hospitals Take Charge

Eric Lerner May 4, 2015 Health Care Without Harm   Across the United States, a growing number of health systems are taking action to address climate change by limiting greenhouse gas emissions, reducing energy use, and investing in renewables.   Two recent success stories highlight this trend. In November, Gundersen Health became the first energy independent health system in the nation. Last mo...

EMA recommends eight drugs for approval

The EMA has recommended eight medicines for approval in a round of reviews, including four new cancer indications. Amgen’s Repatha (evolocumab), the first monoclonal antibody approved to treat high cholesterol, could be a new option for patients who are unable to control their cholesterol using statins. The drug is also indicated for homozygous familial hypercholesterolaemia, a rare inherited di...

Second edition of Pharmaprocess chooses 'biopharmatech' as overarching theme

The forum will bring together professionals in innovation in pharmaceutical manufacturing on 27 and 28 October 

4 Catalan research units receive ‘María de Maeztu’ distinction

Plus, the Institute for Bioengineering of Catalonia has received the ‘Severo Ochoa’ distinction

Samuel Sánchez Ordoñez wins FPdGi 2015 Scientific Research Award

In the previous edition, another Catalan businessman from the biotech sector won in the Business category. 

New inspirations for your lab!

Visit Fritch at ACHEMA 2015: Hall 4.1 • Stand J 49 FRITSCH • Milling and Sizing, an internationally respected manufacturer of application-oriented laboratory instruments for sample preparation and particle sizing, is again one step ahead. Convince yourself and discover the FRITSCH innovations live during ACHEMA 2015: Hall 4.1 • Stand J49!

Montreal to host seventh edition of Summer School on Medicines (SSM7)

University of Barcelona to give three €1,500 grants to attend 

Mitelos to provide business development services in United States

The company has signed a collaboration agreement with Research Triangle, in California

ZeClinics closes largest science crowdfunding campaign of 2015 in Spain

The company has raised €100,000 to research personalized cancer treatments 

KYMOS invests €2 millions in new headquarters at Vallès Technology Park

The company has acquired new technology to expand its R&D and quality control services for the biopharmaceutical industry

US scientists vow to answer CRISPR’s sticky moral questions

Top science academics have launched an initiative to consider emerging human gene-editing tools such as CRISPR-Cas9.

‘Imperative’ hospital pharmacists are given dispensing error defence soon

Society restates concern over lack of defence for hospital pharmacists in official response to government consultation.

Bayer wins Cancer Drugs Fund appeal

Bayer is the only company to win its appeal to NHS England in the latest round of Cancer Drugs Fund reviews. The German firm’s Stivarga (regorafenib) for the treatment of gastrointestinal stromal tumours, will remain on the Fund, while Eisai’s breast cancer medicine Halaven (eribulin) and Lilly’s lung cancer drug Alimta (pemetrexed) lost their appeals and will be dropped in July. read more


Search BioPortfolio:
Loading
Advertisement
Advertisement